Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 5, 1998, Pages 493-498

  Clavel, R ^a   Bousquet, J ^b   Andre C ^c  

^a Clinique du Rhône Moyen   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c Stallergenes SA   (France)

Author keywords

Asthma; Corticotherapy; Grass pollen; Rhinitis; Sublingual immunotherapy

Indexed keywords

BETAMETHASONE; CETIRIZINE; CROMOGLYCATE DISODIUM; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DESENSITIZATION; DOUBLE BLIND PROCEDURE; FEMALE; GRASS; GRASS POLLEN; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031864005     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04086.x     Document Type: Article

References (14)

1. van Nickerk CH, De-Wet JI. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy 1987;17:507-13.
2. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-13.
3. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double-blind study. Allergol Immunopathol (Madr) 1995;23:224-30.
4. Troise C, Voltolini S, Canessa A, Pccora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study. J Invest Allergol Clin Immunol 1995;5:25-30.
5. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18:277-84.
6. Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229-36.
7. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.
8. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797-802.
9. Bousquet J, Hejjaoui A, Clauzel AM, et al. Specific immunotherapy with a standardized Dermatophagoides extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988;82:971-7.
10. Björkstén B, Möller C, Broberger U, et al. The clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy 1986;41:290-5.
11. Möller C, Dreborg S, Lanner A, Björkstén B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986;41:290-5.
12. Creticos PS, Naclerio RM, Adkinson NF, Norman PS. Efficacy, safety and kinetics of oral ragweed immunotherapy in the treatment of allergic seasonal rhinitis. J Allergy Clin Immunol 1990;85:165.
13. van Wilsen EJG, van Hoogstraten IMW, et al. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128-32.
14. + T cells. J Immunol 1995;154:5071-9.